{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:38Z","timestamp":1786984358371,"version":"build-2736575974"},"reference-count":271,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.antiviral.2022.105345","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T02:45:50Z","timestamp":1653101150000},"page":"105345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Animal models for studying coronavirus infections and developing antiviral agents and vaccines"],"prefix":"10.1016","volume":"203","author":[{"given":"Qisheng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunni","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinding","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2978-1248","authenticated-orcid":false,"given":"Jianxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2022.105345_bib3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/infdis\/jiab361","article-title":"Molnupiravir inhibits replication of the emerging SARS-CoV-2 variants of concern in a hamster infection model","volume":"224","author":"Abdelnabi","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103595","article-title":"The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model","volume":"72","author":"Abdelnabi","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.antiviral.2022.105345_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41467-022-28354-0","article-title":"The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern","volume":"13","author":"Abdelnabi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib6","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1128\/JVI.03427-14","article-title":"Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease","volume":"89","author":"Agrawal","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s15010-015-0720-y","article-title":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)","volume":"43","author":"Arabi","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.antiviral.2022.105345_bib8","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105345_bib12","series-title":"Reinfection Could Not Occur in SARS-CoV-2 Infected Rhesus Macaques, bioRxiv : the Preprint Server for Biology","author":"Bao","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105345_bib13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-021-00618-z","article-title":"Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza","volume":"6","author":"Bao","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.antiviral.2022.105345_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/095632020601700505","article-title":"Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB\/c mice","volume":"17","author":"Barnard","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2022.105345_bib15","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1126\/science.abe2402","article-title":"REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters","volume":"370","author":"Baum","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of covid-19 - preliminary report. Reply","volume":"383","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109433","article-title":"A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations","volume":"36","author":"Bertoglio","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2022.105345_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/mco2.98","article-title":"Animal models for SARS-CoV-2 infection and pathology","volume":"2","author":"Bi","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.antiviral.2022.105345_bib19","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice","volume":"101","author":"Bisht","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.antiviral.2022.105345_bib20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.virol.2005.01.042","article-title":"Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein","volume":"334","author":"Bisht","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2022.105345_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41587-021-00822-w","article-title":"Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents","volume":"39","author":"Blanchard","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.antiviral.2022.105345_bib22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.ymthe.2020.12.016","article-title":"Synergistic and antagonistic drug combinations against SARS-CoV-2","volume":"29","author":"Bobrowski","year":"2021","journal-title":"Mol. Ther. : J. Am. Soc. Gene. Ther."},{"key":"10.1016\/j.antiviral.2022.105345_bib23","first-page":"2801","volume":"vol. 289","author":"Booth","year":"2003"},{"key":"10.1016\/j.antiviral.2022.105345_bib24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.5471","article-title":"Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19)","volume":"251","author":"Bourgonje","year":"2020","journal-title":"J. Pathol."},{"key":"10.1016\/j.antiviral.2022.105345_bib25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41541-020-00279-z","article-title":"Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters","volume":"6","author":"Brocato","year":"2021","journal-title":"NPJ Vaccine"},{"key":"10.1016\/j.antiviral.2022.105345_bib26","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2021.01.035","article-title":"Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection","volume":"184","author":"Brouwer","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib27","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1073\/pnas.0403492101","article-title":"Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity","volume":"101","author":"Buchholz","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.antiviral.2022.105345_bib29","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/d41586-021-03552-w","article-title":"Heavily mutated Omicron variant puts scientists on alert","volume":"600","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib30","volume":"vol. 26","author":"Campbell","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105345_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2022.105345_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.chom.2020.07.018","article-title":"Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis in mice","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2022.105345_bib34","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with lopinavir\/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib35","series-title":"Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility","author":"Chan","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105345_bib36","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.abc4776","article-title":"SARS-CoV-2 infection protects against rechallenge in rhesus macaques","volume":"369","author":"Chandrashekar","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib37","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/JVI.79.5.2678-2688.2005","article-title":"Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib38","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/infdis\/jix209","article-title":"Human neutralizing monoclonal antibody inhibition of Middle East respiratory syndrome coronavirus replication in the common marmoset","volume":"215","author":"Chen","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41392-021-00740-y","article-title":"ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.antiviral.2022.105345_bib40","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1128\/JVI.03764-13","article-title":"Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection","volume":"88","author":"Cockrell","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib41","doi-asserted-by":"crossref","first-page":"16226","DOI":"10.1038\/nmicrobiol.2016.226","article-title":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome","volume":"2","author":"Cockrell","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.antiviral.2022.105345_bib42","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib43","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.abl8912","article-title":"Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates","volume":"374","author":"Corbett","year":"2021","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/science.abj0299","article-title":"Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","volume":"373","author":"Corbett","year":"2021","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib45","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41590-021-01021-0","article-title":"mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates","volume":"22","author":"Corbett","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2022.105345_bib46","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1038\/s41467-021-26760-4","article-title":"Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets","volume":"12","author":"Cox","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41564-020-00835-2","article-title":"Therapeutically administered ribonucleoside analogue MK-4482\/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets","volume":"6","author":"Cox","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.antiviral.2022.105345_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2022.105345_bib50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.coviro.2021.06.007","article-title":"Animal models of SARS-CoV-2 transmission","volume":"50","author":"de Vries","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069127","article-title":"The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters","volume":"8","author":"de Wit","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105345_bib52","doi-asserted-by":"crossref","first-page":"16598","DOI":"10.1073\/pnas.1310744110","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques","volume":"110","author":"de Wit","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.antiviral.2022.105345_bib53","series-title":"Reduced Neutralisation of SARS-CoV-2 Omicron B.1.1.529 Variant by Post-immunisation Serum. Lancet (London, England)","author":"Dejnirattisai","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105345_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00974-21","article-title":"Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model","volume":"12","author":"Dhakal","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2022.105345_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101830","article-title":"SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus","volume":"37","author":"Dhama","year":"2020","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib56","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/path.1440","article-title":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China","volume":"200","author":"Ding","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.antiviral.2022.105345_bib57","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.immuni.2021.06.018","article-title":"COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge","volume":"54","author":"DiPiazza","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2022.105345_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081587","article-title":"A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines","volume":"8","author":"Du","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105345_bib59","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2020.09.035","article-title":"Structurally resolved SARS-CoV-2 antibody shows high efficacy in severely infected hamsters and provides a potent cocktail pairing strategy","volume":"183","author":"Du","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib60","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1038\/s41467-021-25331-x","article-title":"A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants","volume":"12","author":"Du","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.virol.2015.03.017","article-title":"Ferret models of viral pathogenesis","volume":"479\u2013480","author":"Enkirch","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2022.105345_bib62","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/nm.3362","article-title":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques","volume":"19","author":"Falzarano","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004250","article-title":"Infection with MERS-CoV causes lethal pneumonia in the common marmoset","volume":"10","author":"Falzarano","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105345_bib64","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1038\/s41467-020-18077-5","article-title":"An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques","volume":"11","author":"Feng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib65","series-title":"ChAdOx1 nCoV-19 (AZD1222) Protects Hamsters against SARS-CoV-2 B.1.351 and B.1.1.7 Disease. bioRxiv : the Preprint Server for Biology","author":"Fischer","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105345_bib66","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1038\/s41467-021-26178-y","article-title":"ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7","volume":"12","author":"Fischer","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib67","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(03)14962-8","article-title":"Effects of a SARS-associated coronavirus vaccine in monkeys","volume":"362","author":"Gao","year":"2003","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.antiviral.2022.105345_bib68","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13293-020-00304-9","article-title":"Impact of sex and gender on COVID-19 outcomes in Europe","volume":"11","author":"Gebhard","year":"2020","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.antiviral.2022.105345_bib70","doi-asserted-by":"crossref","first-page":"R1014","DOI":"10.1016\/j.cub.2020.08.030","article-title":"How the COVID-19 pandemic highlights the necessity of animal research","volume":"30","author":"Genzel","year":"2020","journal-title":"Curr. Biol. : CB"},{"key":"10.1016\/j.antiviral.2022.105345_bib71","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/427242","article-title":"Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice","volume":"191","author":"Greenough","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib72","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0002-9440(10)62989-6","article-title":"Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus","volume":"167","author":"Greenough","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.antiviral.2022.105345_bib73","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.coviro.2015.06.009","article-title":"Animal models for SARS and MERS coronaviruses","volume":"13","author":"Gretebeck","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib74","article-title":"Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2","author":"Gu","year":"2020","journal-title":"Sci. Bull."},{"key":"10.1016\/j.antiviral.2022.105345_bib75","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.abc4730","article-title":"Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy","volume":"369","author":"Gu","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib76","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1016\/j.vaccine.2020.10.064","article-title":"NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge","volume":"38","author":"Guebre-Xabier","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2022.105345_bib77","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/S0140-6736(13)60982-4","article-title":"Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission","volume":"381","author":"Guery","year":"2013","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.antiviral.2022.105345_bib78","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.chom.2020.12.016","article-title":"Induction of alarmin S100A8\/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19","volume":"29","author":"Guo","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2022.105345_bib79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1165\/rcmb.2020-0354OC","article-title":"Lung expression of human angiotensin-converting enzyme 2 sensitizes the mouse to SARS-CoV-2 infection","volume":"64","author":"Han","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.antiviral.2022.105345_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.06.011","article-title":"A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies","volume":"182","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal Chad vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib82","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.cell.2021.05.040","article-title":"Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques","volume":"184","author":"He","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0140-6736(21)02657-X","article-title":"Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management","volume":"399","author":"Heskin","year":"2022","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.antiviral.2022.105345_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.03.051","article-title":"TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation","author":"Ho","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib85","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2020.11.007","article-title":"Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques","volume":"184","author":"Hoang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib86","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib87","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.antiviral.2022.105345_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-021-00784-w","article-title":"Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection","volume":"29","author":"Hwang","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.antiviral.2022.105345_bib89","doi-asserted-by":"crossref","first-page":"16587","DOI":"10.1073\/pnas.2009799117","article-title":"Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development","volume":"117","author":"Imai","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.antiviral.2022.105345_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9040324","article-title":"BNT162b2 vaccine encoding the SARS-CoV-2 P2 S protects transgenic hACE2 mice against COVID-19","volume":"9","author":"Ji","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.antiviral.2022.105345_bib91","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cell.2020.05.027","article-title":"Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2","volume":"182","author":"Jiang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib92","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41385-020-00340-z","article-title":"Animal and translational models of SARS-CoV-2 infection and COVID-19","volume":"13","author":"Johansen","year":"2020","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.antiviral.2022.105345_bib93","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf1906","article-title":"The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in non-human primates","author":"Jones","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib94","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.02077-21","article-title":"Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning?","volume":"96","author":"Jung","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9030214","article-title":"Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine: preclinical studies","volume":"9","author":"Kandeil","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.antiviral.2022.105345_bib96","doi-asserted-by":"crossref","first-page":"26955","DOI":"10.1073\/pnas.2014441117","article-title":"Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity","volume":"117","author":"Kaptein","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.antiviral.2022.105345_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223684","article-title":"Development of a recombinant replication-deficient rabies virus-based bivalent-vaccine against MERS-CoV and rabies virus and its humoral immunogenicity in mice","volume":"14","author":"Kato","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105345_bib98","doi-asserted-by":"crossref","DOI":"10.1177\/20587384211002621","article-title":"A review: mechanism of action of antiviral drugs","volume":"35","author":"Kausar","year":"2021","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.antiviral.2022.105345_bib99","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.chom.2020.03.023","article-title":"Infection and rapid transmission of SARS-CoV-2 in ferrets","volume":"27","author":"Kim","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2022.105345_bib100","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41467-020-20602-5","article-title":"A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein","volume":"12","author":"Kim","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib101","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1016\/j.vaccine.2007.04.065","article-title":"Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques","volume":"25","author":"Kobinger","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2022.105345_bib102","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/infdis\/jiaa486","article-title":"Transient lymphopenia and interstitial pneumonia with endotheliitis in SARS-CoV-2-infected macaques","volume":"222","author":"Koo","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib103","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.cell.2020.09.049","article-title":"A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model","volume":"183","author":"Kreye","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib104","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.antiviral.2011.02.003","article-title":"Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB\/c mouse model by stinging nettle lectin, Urtica dioica agglutinin","volume":"90","author":"Kumaki","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105345_bib106","first-page":"1375","volume":"vol. 372","author":"Kupferschmidt","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105345_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009383","article-title":"Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model","volume":"17","author":"Kurup","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105345_bib108","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41467-021-21918-6","article-title":"SARS-CoV and SARS-CoV-2 are transmitted through the air between ferrets over more than one meter distance","volume":"12","author":"Kutter","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib109","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s42003-021-02443-0","article-title":"ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models","volume":"4","author":"Lambe","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.antiviral.2022.105345_bib110","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ebiom.2015.08.031","article-title":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge","volume":"2","author":"Lan","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.antiviral.2022.105345_bib111","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1371\/journal.pmed.0030149","article-title":"Cynomolgus macaque as an animal model for severe acute respiratory syndrome","volume":"3","author":"Lawler","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib112","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa030685","article-title":"A major outbreak of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib113","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.gastro.2003.08.001","article-title":"Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection","volume":"125","author":"Leung","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2022.105345_bib114","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/01.CIR.0000094737.21775.32","article-title":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study","volume":"108","author":"Li","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.antiviral.2022.105345_bib115","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm1280","article-title":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque","volume":"11","author":"Li","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib116","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib117","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/cr.2015.113","article-title":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2022.105345_bib118","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/infdis\/jiv499","article-title":"Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4","volume":"213","author":"Li","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib119","first-page":"29832","article-title":"Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection","volume":"vol. 117","author":"Li","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105345_bib120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2020.09.007","article-title":"High potency of a bivalent human V(H) domain in SARS-CoV-2 animal models","volume":"183","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib121","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41392-021-00783-1","article-title":"Intranasal delivery of replicating mRNA encoding neutralizing antibody against SARS-CoV-2 infection in mice","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.antiviral.2022.105345_bib122","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00970-21","article-title":"The TMPRSS2 inhibitor nafamostat reduces SARS-CoV-2 pulmonary infection in mouse models of COVID-19","volume":"12","author":"Li","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2022.105345_bib123","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1038\/s41467-021-26539-7","article-title":"Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants","volume":"12","author":"Li","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib124","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/22221751.2021.1887767","article-title":"A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques","volume":"10","author":"Li","year":"2021","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2022.105345_bib125","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41422-022-00618-w","article-title":"SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination","volume":"32","author":"Li","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2022.105345_bib126","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1021\/acs.jmedchem.0c01929","article-title":"Remdesivir metabolite GS-441524 effectively inhibits SARS-CoV-2 infection in mouse models","volume":"65","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2022.105345_bib127","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41467-021-21634-1","article-title":"S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates","volume":"12","author":"Liang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib128","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s15010-020-01557-7","article-title":"Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence","volume":"49","author":"Lin","year":"2021","journal-title":"Infection"},{"key":"10.1016\/j.antiviral.2022.105345_bib129","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.antiviral.2017.12.007","article-title":"A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization","volume":"150","author":"Liu","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105345_bib130","article-title":"One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection","volume":"vol. 118","author":"Liu","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105345_bib131","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41392-020-00269-6","article-title":"Comparison of nonhuman primates identified the suitable model for COVID-19","volume":"5","author":"Lu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.antiviral.2022.105345_bib132","article-title":"A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike","volume":"vol. 118","author":"Lu","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105345_bib133","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41422-020-00414-4","article-title":"Effective treatment of SARS-CoV-2-infected rhesus macaques by attenuating inflammation","volume":"31","author":"Lu","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2022.105345_bib134","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1061","article-title":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo","volume":"8","author":"Luke","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib135","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","article-title":"Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses","volume":"53","author":"Ma","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2022.105345_bib136","first-page":"n2422","article-title":"Covid-19: molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, MSD reports","volume":"375","author":"Mahase","year":"2021","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib137","first-page":"n2713","article-title":"Covid-19: pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports","volume":"375","author":"Mahase","year":"2021","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib138","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1038\/s41467-021-26354-0","article-title":"COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models","volume":"12","author":"Maisonnasse","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib139","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1128\/JVI.01815-15","article-title":"A highly immunogenic and protective Middle East respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform","volume":"89","author":"Malczyk","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41541-021-00315-6","article-title":"ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets","volume":"6","author":"Marsh","year":"2021","journal-title":"NPJ Vaccine"},{"key":"10.1016\/j.antiviral.2022.105345_bib141","article-title":"In vitro characterisation of SARS-CoV-2 and susceptibility of domestic ferrets (Mustela putorius furo)","author":"Marsh","year":"2021","journal-title":"Transboundary Emerg. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib142","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.virol.2004.09.030","article-title":"Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys","volume":"330","author":"McAuliffe","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2022.105345_bib143","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/JVI.02012-06","article-title":"Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus","volume":"81","author":"McCray","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib144","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1073\/pnas.1517719113","article-title":"SARS-like WIV1-CoV poised for human emergence","volume":"113","author":"Menachery","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2022.105345_bib145","first-page":"2012","article-title":"Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV","volume":"24","author":"Meo","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.antiviral.2022.105345_bib146","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","volume":"586","author":"Mercado","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib147","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148036","article-title":"Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infection","volume":"131","author":"Meyer","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2022.105345_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102054","article-title":"Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model","volume":"24","author":"Mohandas","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.antiviral.2022.105345_bib149","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001567","article-title":"Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2","volume":"102","author":"Monchatre-Leroy","year":"2021","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib150","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2022.105345_bib151","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-020-2324-7","article-title":"Respiratory disease in rhesus macaques inoculated with SARS-CoV-2","volume":"585","author":"Munster","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib152","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib153","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/iub.1709","article-title":"Significance of circulatory DPP4 activity in metabolic diseases","volume":"70","author":"Nargis","year":"2018","journal-title":"IUBMB Life"},{"key":"10.1016\/j.antiviral.2022.105345_bib154","article-title":"Third BNT162b2 vaccination neutralization of SARS-CoV-2 Omicron infection","author":"Nemet","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib155","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.7150\/ijbs.59149","article-title":"Development and application of therapeutic antibodies against COVID-19","volume":"17","author":"Ning","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.antiviral.2022.105345_bib156","series-title":"SARS-CoV-2 B.1.1.7 Infection of Syrian Hamster Does Not Cause More Severe Disease, and Naturally Acquired Immunity Confers Protection","author":"Nu\u00f1ez","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105345_bib157","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib158","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41421-021-00295-w","article-title":"Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries","volume":"7","author":"Pan","year":"2021","journal-title":"Cell Discover."},{"key":"10.1016\/j.antiviral.2022.105345_bib159","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/tbed.13907","article-title":"Animal models for SARS-CoV-2 research: a comprehensive literature review","volume":"68","author":"Pandey","year":"2021","journal-title":"Transboundary Emerg. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib160","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1038\/s41467-020-19741-6","article-title":"Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission","volume":"11","author":"Peckham","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib161","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The severe acute respiratory syndrome","volume":"349","author":"Peiris","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib162","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.antiviral.2022.105345_bib163","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41591-021-01318-5","article-title":"Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies","volume":"27","author":"Planas","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib164","article-title":"Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2","volume":"138","author":"Plante","year":"2021","journal-title":"Biomed. Pharmacolther."},{"key":"10.1016\/j.antiviral.2022.105345_bib165","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103153","article-title":"Prophylactic intranasal administration of a TLR2\/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model","volume":"63","author":"Proud","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.antiviral.2022.105345_bib167","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.vaccine.2005.06.038","article-title":"Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine","volume":"24","author":"Qin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2022.105345_bib168","volume":"vol. 32","author":"Qin","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105345_bib169","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2016.06.003","article-title":"Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection","volume":"132","author":"Qiu","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2022.105345_bib170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib171","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3201\/eid2008.140663","article-title":"Isolation of MERS coronavirus from a dromedary camel, Qatar","volume":"20","author":"Raj","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib172","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/JVI.02935-13","article-title":"Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus","volume":"88","author":"Raj","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib173","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009392","article-title":"Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry","volume":"17","author":"Ren","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105345_bib174","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1038\/s41467-020-17367-2","article-title":"SARS-CoV-2 is transmitted via contact and via the air between ferrets","volume":"11","author":"Richard","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib175","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1128\/JVI.79.9.5833-5838.2005","article-title":"Aged BALB\/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans","volume":"79","author":"Roberts","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib176","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/JVI.79.1.503-511.2005","article-title":"Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters","volume":"79","author":"Roberts","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib177","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/500143","article-title":"Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters","volume":"193","author":"Roberts","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib178","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018558","article-title":"Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaques","volume":"6","author":"Rockx","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2022.105345_bib179","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1126\/science.abb7314","article-title":"Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model","volume":"368","author":"Rockx","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib180","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1038\/s41467-021-26117-x","article-title":"SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques","volume":"12","author":"Roozendaal","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib181","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1080\/22221751.2020.1858177","article-title":"Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection","volume":"9","author":"Rosenke","year":"2020","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2022.105345_bib182","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1038\/s41467-021-22580-8","article-title":"Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model","volume":"12","author":"Rosenke","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib183","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2021.02.001","article-title":"A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs","volume":"54","author":"Routhu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2022.105345_bib184","doi-asserted-by":"crossref","first-page":"11401","DOI":"10.1128\/JVI.78.20.11401-11404.2004","article-title":"Macaque model for severe acute respiratory syndrome","volume":"78","author":"Rowe","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2021.06.016","article-title":"Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant","volume":"566","author":"Ryu","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib186","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00134-021-06395-1","article-title":"Camostat mesylate therapy in critically ill patients with COVID-19 pneumonia","volume":"47","author":"Sakr","year":"2021","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib187","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41467-021-21389-9","article-title":"Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19","volume":"12","author":"Salguero","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib188","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41586-020-3035-9","article-title":"A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate","volume":"590","author":"Sanchez-Felipe","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib189","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201993","article-title":"Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo","volume":"218","author":"Sch\u00e4fer","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib190","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41422-020-0364-z","article-title":"Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques","volume":"30","author":"Shan","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2022.105345_bib191","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib192","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virusres.2007.03.012","article-title":"A review of studies on animal reservoirs of the SARS coronavirus","volume":"133","author":"Shi","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2022.105345_bib193","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1126\/science.abb7015","article-title":"Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2","volume":"368","author":"Shi","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib194","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib195","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/22221751.2021.1899770","article-title":"The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract","volume":"10","author":"Shi","year":"2021","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2022.105345_bib196","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","article-title":"Pathogenesis and transmission of SARS-CoV-2 in golden hamsters","volume":"583","author":"Sia","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib197","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41564-020-00841-4","article-title":"Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets","volume":"6","author":"Singh","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.antiviral.2022.105345_bib198","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000756","article-title":"Exacerbated innate host response to SARS-CoV in aged non-human primates","volume":"6","author":"Smits","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105345_bib199","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202756","article-title":"Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP","volume":"218","author":"Solforosi","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib200","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s42003-021-02029-w","article-title":"Structure and function analysis of a potent human neutralizing antibody CA521(FALA) against SARS-CoV-2","volume":"4","author":"Song","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.antiviral.2022.105345_bib201","series-title":"DPP4 Inhibition: Preventing SARS-CoV-2 Infection And\/or Progression of COVID-19? Diabetes Metab Res Rev","author":"Strollo","year":"2020"},{"key":"10.1016\/j.antiviral.2022.105345_bib202","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1128\/JVI.78.7.3572-3577.2004","article-title":"Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice","volume":"78","author":"Subbarao","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1208\/s12248-020-00459-8","article-title":"Remdesivir for treatment of COVID-19: combination of pulmonary and IV administration may offer aditional benefit","volume":"22","author":"Sun","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.antiviral.2022.105345_bib204","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cell.2020.06.010","article-title":"Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment","volume":"182","author":"Sun","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib205","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","article-title":"A mouse model of SARS-CoV-2 infection and pathogenesis","volume":"28","author":"Sun","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2022.105345_bib206","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8040771","article-title":"A newcastle disease virus (NDV) expressing a membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine","volume":"8","author":"Sun","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.antiviral.2022.105345_bib207","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.virol.2015.02.030","article-title":"Development of animal models against emerging coronaviruses: from SARS to MERS coronavirus","volume":"479\u2013480","author":"Sutton","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2022.105345_bib208","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","article-title":"Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant","volume":"603","author":"Suzuki","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib209","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(04)16506-9","article-title":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets","volume":"363","author":"ter Meulen","year":"2004","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.antiviral.2022.105345_bib210","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41467-020-20653-8","article-title":"SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice","volume":"12","author":"Tian","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib211","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-1070-6","article-title":"Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters","author":"Tostanoski","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib212","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj3789","article-title":"Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern","volume":"13","author":"Tostanoski","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127377","article-title":"The SARS-CoV-2 main protease as drug target","volume":"30","author":"Ullrich","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.antiviral.2022.105345_bib214","first-page":"985","volume":"vol. 36","author":"Vabret","year":"2003"},{"key":"10.1016\/j.antiviral.2022.105345_bib215","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","volume":"52","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2022.105345_bib216","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1354\/vp.45-4-551","article-title":"Pathology of experimental SARS coronavirus infection in cats and ferrets","volume":"45","author":"van den Brand","year":"2008","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.antiviral.2022.105345_bib217","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1574-6976.2006.00032.x","article-title":"Human coronavirus NL63, a new respiratory virus","volume":"30","author":"van der Hoek","year":"2006","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2022.105345_bib218","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41541-021-00301-y","article-title":"Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease","volume":"6","author":"van der Lubbe","year":"2021","journal-title":"NPJ Vaccine"},{"key":"10.1016\/j.antiviral.2022.105345_bib219","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1128\/JVI.00676-14","article-title":"Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4","volume":"88","author":"van Doremalen","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib220","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba8399","article-title":"A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques","volume":"6","author":"van Doremalen","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.antiviral.2022.105345_bib221","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","volume":"586","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib222","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"van Doremalen","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib223","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-pharmtox-010818-021511","article-title":"Systems pharmacology: defining the interactions of drug combinations","volume":"59","author":"van Hasselt","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.antiviral.2022.105345_bib224","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009688","article-title":"Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques","volume":"17","author":"Van Rompay","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105345_bib225","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.immuni.2021.08.016","article-title":"A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope","volume":"54","author":"VanBlargan","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2022.105345_bib226","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bbrc.2021.03.096","article-title":"ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model","volume":"555","author":"Vandyck","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib227","doi-asserted-by":"crossref","first-page":"761250","DOI":"10.3389\/fimmu.2021.761250","article-title":"XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants","volume":"12","author":"Vanhove","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2022.105345_bib228","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib229","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant modified vaccinia virus ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"89","author":"Volz","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib230","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(21)01290-3","article-title":"Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination","volume":"397","author":"Wall","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.antiviral.2022.105345_bib231","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/infdis\/jit393","article-title":"Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations","volume":"208","author":"Walsh","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib232","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib233","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","article-title":"Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib234","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","article-title":"Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib235","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s13238-020-00767-x","article-title":"Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB\/c and C57BL\/6J mice","volume":"11","author":"Wang","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib236","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1038\/s41467-020-19568-1","article-title":"Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib237","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41423-020-0447-2","article-title":"High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients","volume":"17","author":"Wang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2022.105345_bib238","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.antiviral.2022.105345_bib239","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41422-020-00450-0","article-title":"Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models","volume":"31","author":"Wang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2022.105345_bib240","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chom.2021.04.007","article-title":"Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization","volume":"29","author":"Wang","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2022.105345_bib241","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib242","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus","volume":"69","author":"Weiss","year":"2005","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.antiviral.2022.105345_bib243","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.03347-21","article-title":"Drug combinations as a first line of defense against coronaviruses and other emerging viruses","volume":"12","author":"White","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2022.105345_bib244","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-020-2423-5","article-title":"Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2","volume":"585","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib245","article-title":"SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function","author":"Winkler","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2022.105345_bib246","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1086\/497151","article-title":"Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia","volume":"192","author":"Woo","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2022.105345_bib247","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1128\/JVI.06540-11","volume":"86","author":"Woo","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib248","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib249","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib250","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1038\/s41467-020-17972-1","article-title":"A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib251","article-title":"Original hosts, clinical features, transmission routes, and vaccine development for coronavirus disease (COVID-19)","volume":"8","author":"Wu","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib252","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib253","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-021-21639-w","article-title":"Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques","volume":"12","author":"Yadav","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib254","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1038\/s41467-020-20228-7","article-title":"A single dose of recombinant VSV-\u0394G-spike vaccine provides protection against SARS-CoV-2 challenge","volume":"11","author":"Yahalom-Ronen","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib255","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature02463","article-title":"A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice","volume":"428","author":"Yang","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib256","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25891","article-title":"Analysis of 92 deceased patients with COVID-19","author":"Yang","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2022.105345_bib257","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2022.105345_bib258","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/22221751.2021.1885998","article-title":"Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection","volume":"10","author":"Ye","year":"2021","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2022.105345_bib259","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41423-020-0458-z","article-title":"Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies","volume":"17","author":"Yi","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2022.105345_bib260","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.abc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","volume":"369","author":"Yu","year":"2020","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.antiviral.2022.105345_bib261","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41586-021-03732-8","article-title":"Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques","volume":"596","author":"Yu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib262","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/s41564-020-00802-x","article-title":"Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters","volume":"5","author":"Yuan","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.antiviral.2022.105345_bib263","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41392-021-00552-0","article-title":"Gender associates with both susceptibility to infection and pathogenesis of SARS-CoV-2 in Syrian hamster","volume":"6","author":"Yuan","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.antiviral.2022.105345_bib264","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41586-021-03431-4","article-title":"Clofazimine broadly inhibits coronaviruses including SARS-CoV-2","volume":"593","author":"Yuan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib265","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03431-4","article-title":"Clofazimine broadly inhibits coronaviruses including SARS-CoV-2","author":"Yuan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib266","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2022.105345_bib267","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.cell.2020.07.024","article-title":"A thermostable mRNA vaccine against COVID-19","volume":"182","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2022.105345_bib268","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.cub.2020.03.063","article-title":"Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak","volume":"30","author":"Zhang","year":"2020","journal-title":"Curr. Biol. : CB"},{"key":"10.1016\/j.antiviral.2022.105345_bib269","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41392-021-00852-5","article-title":"SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.antiviral.2022.105345_bib270","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.antiviral.2022.105345_bib271","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1038\/s41467-021-25153-x","article-title":"Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics","volume":"12","author":"Zhao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2022.105345_bib272","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008949","article-title":"Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: a nonhuman primate model of COVID-19 progression","volume":"16","author":"Zheng","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2022.105345_bib273","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib274","series-title":"Robust SARS-CoV-2 Infection in Nasal Turbinates after Treatment with Systemic Neutralizing Antibodies","author":"Zhou","year":"2021"},{"key":"10.1016\/j.antiviral.2022.105345_bib275","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/2472555220942123","article-title":"RNA-dependent RNA polymerase as a target for COVID-19 drug discovery","volume":"25","author":"Zhu","year":"2020","journal-title":"SLAS Discover. : Adv. Life Sci. R D"},{"key":"10.1016\/j.antiviral.2022.105345_bib276","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"Zost","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2022.105345_bib277","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41422-020-00398-1","article-title":"25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor","volume":"30","author":"Zu","year":"2020","journal-title":"Cell Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222001140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354222001140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:36:41Z","timestamp":1759063001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354222001140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":271,"alternative-id":["S0166354222001140"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105345","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Animal models for studying coronavirus infections and developing antiviral agents and vaccines","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2022.105345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105345"}}